Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

AUTOR(ES)

Polonelli, L

RESUMO

Rat monoclonal yeast killer toxin (KT)-like immunoglobulin M (IgM) anti-idiotypic antibodies (KT-IdAbs) were produced by idiotypic vaccination with a mouse monoclonal antibody (MAb; MAb KT4) that neutralized a Pichia anomala KT characterized by a wide spectrum of antimicrobial activity. The characteristics of the KT-IdAbs were demonstrated by their capacity to compete with the KT to the idiotype of MAb KT4 and to interact with putative KT cell wall receptors (KTRs) of sensitive Candida albicans cells. The internal-image properties of KT-IdAbs were proven by their killer activity against KT-sensitive yeasts. This lethal effect was abolished by prior adsorption of KT-IdAbs with MAb KT4. These findings stressed the potential importance of antibody-mediated immunoprotection against candidiasis and suggested a feasible experimental approach for producing antimicrobial receptor antibodies without purifying the receptor. KT-IdAbs might represent the basis for producing engineered derivatives with a high potential for effective therapeutic antifungal activity.

Documentos Relacionados

• Yeast killer toxin-like anti-idiotypic antibodies.
• Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
• Induction of immune response to influenza virus with anti-idiotypic antibodies.
• Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies.
• A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies.